G1 Therapeutics, Inc. (GTHX) financial statements (2021 and earlier)

Company profile

Business Address 700 PARK OFFICES DRIVE
RESEARCH TRIANGLE PARK, NC 27709
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments269369104
Cash and cash equivalents269369104
Restricted cash and investments0  
Other undisclosed current assets211
Total current assets:271370105
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment411
Other undisclosed noncurrent assets0  
Total noncurrent assets:1411
TOTAL ASSETS:285371105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities191212
Accounts payable434
Accrued liabilities1598
Other liabilities1  
Total current liabilities:201212
Noncurrent Liabilities
Long-term debt and lease obligation10  
Operating lease, liability10
Liabilities, other than long-term debt 00
Other liabilities 00
Total noncurrent liabilities:1000
Total liabilities:291212
Stockholders' equity
Stockholders' equity attributable to parent25635993
Common stock000
Treasury stock, value(0)(0)(0)
Additional paid in capital592573223
Accumulated deficit(337)(214)(129)
Total stockholders' equity:25635993
TOTAL LIABILITIES AND EQUITY:285371105

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Operating expenses(129)(89)(61)
Operating loss:(129)(89)(61)
Nonoperating income
(Other Nonoperating income)
741
Net loss attributable to parent:(122)(85)(60)
Preferred stock dividends and other adjustments  (5)
Net loss available to common stockholders, diluted:(122)(85)(65)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(122)(85)(60)
Comprehensive loss, net of tax, attributable to parent:(122)(85)(60)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: